Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.

Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH.

Mov Disord. 2011 Feb 1;26(2):289-96. doi: 10.1002/mds.23477. Epub 2011 Mar 2.

PMID:
21370255
2.

Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.

Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH.

Neurology. 2010 Nov 30;75(22):2009-16. doi: 10.1212/WNL.0b013e3181ff96bf.

PMID:
21115956
3.

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ.

Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9.

PMID:
21060094
4.

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.

Br√łnnick K, Alves G, Aarsland D, Tysnes OB, Larsen JP.

Neuropsychology. 2011 Jan;25(1):114-24. doi: 10.1037/a0020857.

PMID:
20954781
5.

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M.

Neurology. 2010 Sep 21;75(12):1062-9. doi: 10.1212/WNL.0b013e3181f39d0e.

6.

Biomarkers of PD progression: is CSF the answer?

Aarsland D, Ravina B.

Neurology. 2010 Sep 21;75(12):1036-7. doi: 10.1212/WNL.0b013e3181f6f272. Epub 2010 Aug 25. No abstract available.

PMID:
20739641
7.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.

Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.

Neurobiol Aging. 2011 Dec;32(12):2322.e19-27. doi: 10.1016/j.neurobiolaging.2010.05.023. Epub 2010 Jul 1.

8.

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia.

Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM.

Mov Disord. 2010 Apr 30;25(6):687-95. doi: 10.1002/mds.22799.

9.

Association between cognition and function in patients with Parkinson disease with and without dementia.

Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A.

Mov Disord. 2010 Jul 15;25(9):1170-6. doi: 10.1002/mds.23073.

10.

Gray matter correlations of cognition in incident Parkinson's disease.

Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, Bronnick K, Tysnes OB, Antulov R, Dwyer MG, Aarsland D.

Mov Disord. 2010 Apr 15;25(5):629-33. doi: 10.1002/mds.22867.

PMID:
20213820
11.

Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.

Lyoo CH, Ryu YH, Lee MS.

Mov Disord. 2010 Mar 15;25(4):496-9. doi: 10.1002/mds.22975.

PMID:
20108369
12.

MRI and cognitive impairment in Parkinson's disease.

Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ.

Mov Disord. 2009;24 Suppl 2:S748-53. doi: 10.1002/mds.22670. Review.

PMID:
19877242
13.

The morbid anatomy of dementia in Parkinson's disease.

Kalaitzakis ME, Pearce RK.

Acta Neuropathol. 2009 Nov;118(5):587-98. doi: 10.1007/s00401-009-0597-x. Epub 2009 Oct 10. Review.

PMID:
19820956
14.

Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.

Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):295-7. doi: 10.1097/WAD.0b013e31819c5ef4.

15.

Temporal lobe changes in early, untreated Parkinson's disease.

Martin WR, Wieler M, Gee M, Camicioli R.

Mov Disord. 2009 Oct 15;24(13):1949-54. doi: 10.1002/mds.22680.

PMID:
19606493
16.

A role for the human amygdala in higher cognition.

Schaefer A, Gray JR.

Rev Neurosci. 2007;18(5):355-63. Review.

PMID:
19544622
17.

Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease.

Aybek S, Lazeyras F, Gronchi-Perrin A, Burkhard PR, Villemure JG, Vingerhoets FJ.

Parkinsonism Relat Disord. 2009 Aug;15(7):521-4. doi: 10.1016/j.parkreldis.2009.01.003. Epub 2009 Apr 5.

PMID:
19349206
18.

Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.

Misra C, Fan Y, Davatzikos C.

Neuroimage. 2009 Feb 15;44(4):1415-22. doi: 10.1016/j.neuroimage.2008.10.031. Epub 2008 Nov 5.

19.

Neuropsychiatric problems in Parkinson's disease: comparisons between self and caregiver report.

McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D.

Aging Ment Health. 2008 Sep;12(5):647-53. doi: 10.1080/13607860802343225.

PMID:
18855181
20.

Supplemental Content

Support Center